Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with multiple myeloma (a type of blood cancer)
- People who have one or more confirmed damaged areas in the spine between the mid-back and lower back (between the 6th thoracic and 5th lumbar vertebrae)
- People who have 4 or fewer spinal fractures
- People whose relevant pain started within the last 3 months
- People whose spine treatment can be completed in a single procedure
- People whose pain level is rated 5 or higher on a standard 0–10 pain scale
Who may not be able to join:
- People who have neurological problems, such as weakness, numbness, or loss of function caused by nerve damage
- People who have a psychological or psychiatric condition that doctors believe could make it difficult to follow the trial's requirements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mikkel Andersen, Professor, Centre of Spine Surgery and Research, Middelfart Hospital
Phone: +4524411994
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Improvement in back-specific disability
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.